The management of postsurgical pain with patient-controlled analgesia pumps may be safe, as indicated by a low rate of device-related error.
The FDA Digital Health Software Precertification Program represents a feasible solution to regulate software classified as a medical device.
The FDA has approved 2 new migraine treatment devices to stop and prevent migraine attacks in adults.
Researchers are urging legislators to assign ICD codes to all medical devices, which could help identify device-related adverse effects more accurately.
About half of U.S. doctors received payments from the pharmaceutical and medical device industries in 2015.
Bayer announced the launch of Aleve Direct Therapy, a pain relief device.
Clinical Pain Advisor Articles
- Stages of Low Back Pain Have Specific Sets of Clinical Indicators
- FDA Approves Aimovig for Migraine Prevention
- Pain Interference Associated With Depression, Pain Self-Efficacy in Chronic Musculoskeletal Pain
- Factors Associated With Neuropathic Pain in Ankylosing Spondylitis
- Detox vs Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: Expert Roundtable
- Effect of Prescription Drug Monitoring Programs on Fatal, Nonfatal Drug Overdoses
- Standardized SCS Workflow May Effectively Alleviate Failed Back Surgery Syndrome-Related Pain
- Marijuana Legalization and Opioid Prescribing Rates
- Medical Marijuana Users More Likely to Use Prescription Drugs for Medical, Nonmedical Purposes
- Interbrain Coupling During Handholding Associated With Analgesia, Empathy
- Recommendations Developed for Managing Postpartum Pain
- Cryoablation Efficacious for Cancer Pain, Review Finds
- Art Intervention Clinically Effective in Treating Cancer-Related Pain, Mood Symptoms
- Pain, Cognitive Dysfunction in SLE Mediated by Sleep Disturbance, Depression
- PTSD Symptoms and the Acute Pain Response in Low-Income Women